vaccine

Allergy Therapeutics shares spike on late-stage data

admin — Thu, 15 May 2008 06:59:58 -0400

Shares of the UK's Allergy Therapeutics surged on the news that its experimental hay fever vaccine--Pollinex Quattro--demonstrated positive results in a crucial Phase III study, which they say was Read more...

Novartis touts mid-stage results for MenB

admin — Thu, 15 May 2008 06:59:57 -0400

Novartis says that a mid-stage study of its MenB vaccine demonstrated broad protection from meningococcal B infections in infants. Researchers tracked positive results starting with three Read more...

Cervarix data demonstrates prolonged protection

admin — Thu, 15 May 2008 06:59:56 -0400

GlaxoSmithKline has released new Cervarix data that demonstrates the vaccine's ability to generate a high and sustained level of antibodies to neutralize the two most prevalent strains of cervical Read more...

Vaccine makers to produce record amount of flu jab

admin — Thu, 15 May 2008 06:59:55 -0400

The five key vaccine makers say they plan to produce a record 143 million doses of flu vaccine for the U.S. market next season, which should be enough to satisfy demand. Manufacturers delivered 140 Read more...

WHO warns of rising bird flu pandemic risk

admin — Thu, 08 May 2008 06:59:58 -0400

The headlines may have died down in recent months, but bird flu experts say that the threat of a global pandemic has actually been growing. The World Health Organization outlined the spread of the Read more...

Experts call for long-term immunity tracking studies

admin — Thu, 08 May 2008 06:59:57 -0400

Vaccine experts are pondering just how long vaccines will be able to provide immunity in a world where some diseases are all but eliminated and natural exposure to many common viruses has ended. Read more...

Researchers explore brain cancer vaccine

admin — Thu, 08 May 2008 06:59:56 -0400

Researchers are touting the early results from a study of a new brain cancer vaccine that combines protein antigens extracted from a patient's tumor and matches them with white cells also drawn from Read more...

VaxGen sells anthrax vaccine to its old rival

admin — Thu, 08 May 2008 06:59:55 -0400

Reduced to a skeleton crew and a bleak outlook, South San Francisco-based VaxGen sold its experimental anthrax vaccine to its former chief rival, Emergent BioSolutions, for $2 million down and up to Read more...

FDA orders Merck to fix vaccine plant problems

admin — Thu, 01 May 2008 06:59:57 -0400

The FDA has given Merck 15 days to decide how to fix Read more...

Discovery offers shortcut to custom flu vaccines

admin — Thu, 01 May 2008 06:59:56 -0400

A team of researchers at Emory University and the Oklahoma Medical Research Foundation has found a way to radically upend the way new vaccines are developed to fight a pandemic. Just days after a Read more...